161 related articles for article (PubMed ID: 11589435)
1. The impact of the National Cervical Screening Programme on the presentation of cancer of the cervix in Canterbury.
Simcock B; Sykes P; Laney M
N Z Med J; 2001 Aug; 114(1138):378-80. PubMed ID: 11589435
[TBL] [Abstract][Full Text] [Related]
2. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
3. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
Lewis H; Yeh LC; Almendral B; Neal H
N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
[TBL] [Abstract][Full Text] [Related]
5. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)].
Monchy D; Lieng CR; Kruy LS; Kahler K; Eav S
Bull Soc Pathol Exot; 2005 Sep; 98(3):183-6. PubMed ID: 16267957
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with tumour stage at presentation in invasive cervical cancer.
Ndlovu N; Kambarami R
Cent Afr J Med; 2003; 49(9-10):107-11. PubMed ID: 15298465
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of causes of increased incidence of cervical cancer in Slovenia.
Smrkolj S; Rakar S; Mozina A; Erzen M
Eur J Obstet Gynecol Reprod Biol; 2004 Dec; 117(2):213-21. PubMed ID: 15541860
[TBL] [Abstract][Full Text] [Related]
9. Incidence of cervical carcinoma in a high-risk, non-screened area results of a retrospective analysis on the Dutch Caribbean Antilles from 1983 to 1998.
Bax A; Voigt RR; Coronel CC; Putter H; de Bie Leuving Tjeenk RM; van Marwijk HW
West Indian Med J; 2004 Jun; 53(3):150-4. PubMed ID: 15352742
[TBL] [Abstract][Full Text] [Related]
10. Cervical screening history in patients with early stage carcinoma of the cervix.
Abed Z; O'Leary M; Hand K; Flannelly G; Lenehan P; Murphy J; Foley M
Ir Med J; 2006 May; 99(5):140-2. PubMed ID: 16892918
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of women treated for cervical cancer at Westmead Hospital. Implications for hospital and community-based health services.
Wain G; Ward J; Long D
Aust Health Rev; 1995; 18(3):111-7. PubMed ID: 10152269
[TBL] [Abstract][Full Text] [Related]
12. Changes in epidemiology and clinical characteristics of cervical cancer over the past 50 years.
Zhao EF; Bao L; Li C; Song L; Li YL
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):605-9. PubMed ID: 15958289
[TBL] [Abstract][Full Text] [Related]
13. Screening history in women with cervical cancer in a Danish population-based screening program.
Kirschner B; Poll S; Rygaard C; Wåhlin A; Junge J
Gynecol Oncol; 2011 Jan; 120(1):68-72. PubMed ID: 21035171
[TBL] [Abstract][Full Text] [Related]
14. Geographic & age variations in invasive cervical cancer in Kentucky, 1995-1999.
Wyatt S; Ross FE; Bottorff D; Lancaster M
J Ky Med Assoc; 2002 Oct; 100(10):441-6. PubMed ID: 12395746
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer: changing trends in the Wellington region.
Sadler HB; Lamb DS; Duncan GR; Spry NA; Christie DR; Hanna SJ
N Z Med J; 1993 Apr; 106(954):155-6. PubMed ID: 8479661
[TBL] [Abstract][Full Text] [Related]
17. [Gynecology-obstetrics at the Yalgado-Ouédraogo (Ouagadougou) National Hospital Center. Cancer of the cervix uteri: epidemio-clinical and anatomopathologic aspects].
Lankoandé J; Sakandé B; Ouédraogo A; Ouédraogo CM; Ouattara T; Bonané B; Koné B
Sante; 1997; 7(4):227-30. PubMed ID: 9410446
[TBL] [Abstract][Full Text] [Related]
18. [No major difference between population screening for cervical carcinoma at the present screening interval of 5 years and the former interval of 3 years].
Vinkesteijn AS; Siemens FC; Boon ME; Kuypers JC; Kok LP
Ned Tijdschr Geneeskd; 2004 Sep; 148(36):1781-5. PubMed ID: 15495942
[TBL] [Abstract][Full Text] [Related]
19. Pap smear screening history of women with squamous cell carcinoma and adenocarcinoma of the cervix.
Pak SC; Martens M; Bekkers R; Crandon AJ; Land R; Nicklin JL; Perrin LC; Obermair A
Aust N Z J Obstet Gynaecol; 2007 Dec; 47(6):504-7. PubMed ID: 17991118
[TBL] [Abstract][Full Text] [Related]
20. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000.
Visioli CB; Zappa M; Ciatto S; Iossa A; Crocetti E
Cancer Detect Prev; 2004; 28(6):461-4. PubMed ID: 15582270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
